Skip to main content
Bloomberg Law

Drug, Device Manufacturers to Face Hill Scrutiny in 2019

January 8, 2019
Authors
Jaime L.M. Jones
Combating high drug and device prices is a bipartisan goal in Congress, and House Democrats in control of key oversight committees have made clear their plans to pursue investigations putting pharma CEOs under scrutiny. Manufacturers need to prep now to explain policies and prepare for public relations issues.
View Article

Contacts

Jones, Jaime L.M.
合伙人律师

Capabilities

Suggested News & Insights

Sidley Healthcare Investment Conference 2026Tuesday, September 22, 2026
活动
Sidley Lawyers Jaime Jones, Jennifer Saulino, and Lisa Miller to Speak at the ABA′s 2026 Qui Tam & Civil False Claims and Healthcare Fraud Institute in Washington, D.C.Wednesday, May 27, 2026 – Thursday, May 28, 2026
活动
Vice President and CMS Announce Suite of New Administrative Actions to Further Federal Anti-Fraud Health Care InitiativesMay 20, 2026
Original Source
Sidley Represents Nourish in US$100 Million Series C FinancingMay 19, 2026
公告
Tariff Enforcement at the Forefront: Importer Agrees to Pay $549.5 million in Largest-Ever Trade-Related False Claims Act SettlementMay 18, 2026
Original Source
Sidley Represents MacroGenics in the Sale of Its GMP Manufacturing OperationsMay 11, 2026
公告